Wide range of bioactive effects: Nutraceuticals offer multiple mechanisms of action relevant to CeD pathogenesis, including gliadin degradation or sequestration, inhibition of TG2 enzyme activity, modulation of IP, anti-inflammatory and antioxidant effects and gut microbiota modulation. Here, TGM2 is linked to cranioectodermal dysplasia.